Decor
NEWSLETTER OF THE BASQUE BIOREGION
N 17 | January 2012


  • 27/01/2012

    Biobide publishes the results of its zebrafish research in the journal Oncogene

    [+ info]

  • 23/01/2012

    Biolan Biosensors will monitor the health of Chilean table grapes

    [+ info]

  • 20/01/2012

    CIC bioGUNE celebrates its seventh anniversary

    [+ info]

  • 19/01/2012

    Histocell develops a cell therapy-based lung treatment together with CSIC and the Hospital Clinic

    [+ info]

  • 16/01/2012

    Abbott and CIC biomaGUNE sign an agreement to study the effect of diet on memory and the ageing process

    [+ info]

  • 15/01/2012

    Tecnalia develops new products from unused fruit and vegetable waste

    [+ info]

  • 13/01/2012

    CIC bioGUNE researchers discover a new therapeutic target to fight liver cancer

    [+ info]

  • 12/01/2012

    Creation of the Bioelectronics Aula

    [+ info]

  • 9/01/2012

    Tecnalia and Donostia Hospital develop a breath-based sensor for detecting lung cancer

    [+ info]

  • 3/01/2012

    A&B Laboratories launches a range of chemical and environmental risk-free biological cleaning products

    [+ info]

  • 23/12/2011

    IkerChem increases its capital with investments from venture capital firms

    [+ info]

  • 20/12/2011

    The Santiago Apóstol Hospital takes part of a pioneer European clinical trial to treat acute mania in bipolar disorder

    [+ info]

  • 15/12/2011

    Genetadi Biotech develops genetic test to diagnose idiopathic mental retardation

    [+ info]

  • 14/12/2011

    Neiker-Tecnalia cultivates in vitro microalgae to obtain nutritional molecules for the food industry

    [+ info]

  • 10/12/2011

    High Identity Buildings plans innovative and sustainable labs for biosciences

    [+ info]

  • 9/12/2011

    The Biodonostia Institute studies the genetic mutations responsible for retinitis

    [+ info]

  • 7/12/2011

    Basque Biobank launches brain donation programme

    [+ info]

  • 5/12/2011

    The University of the Basque Country discovers new pathways towards anti-stress medications

    [+ info]

  • 2/12/2011

    Biolan analyses grape quality in the Rioja Alavesa using remote measuring systems

    [+ info]

  • 1/12/2011

    FAES signs an agreement with Kalbe Pharma to market Bilastine in Indonesia

    [+ info]

LEGAL NOTICE
This informative newsletter is the property of Sociedad para la Transformación Competitiva, S.A. (SPRI, S.A.), registered in the Mercantile Register of Álava, volume 256, book 182, section 3, folio 88, sheet 1,614, inscription 1, with company registration number A01021237 and registered offices at Duque de Wellington, nº 2 - 01010 Vitoria-Gasteiz.